Editing
Prostate Cancer: Epidemiology and Pathogenesis
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Molecular Genetics == * Biologic functions of known prostate cancer susceptibility genes include: *# Control of the inflammatory response *# Homeobox genes *# DNA repair mechanisms *# Susceptibility to infection * '''<span style="color:#ff0000">Most common gene fusion identified in localized prostate cancer involves TMPRSS2</span>''' or other promoters (SLC45A3, HERPUD1, or NDRG) '''<span style="color:#ff0000">fused to ERG (ETS-related gene)</span>''' ** '''The TMPRSS2 gene is prostate specific, and is expressed in both benign and malignant prostatic epithelium;''' ** '''TMPRSS2:ERG fusion gene is detected in ≈50% of prostate cancers''' ** '''TMPRSS2-ERG fusion gene is present in prostate stem cells''' ** '''TMPRSS2 expression has been shown to be induced by androgens''' ** '''TRMPSS2-related gene fusions are highly specific for the presence of prostate cancer''' * Most common point mutations in prostate cancer are mutations in SPOP, which encodes a subunit of ubiquitin ligase * Current evidence suggests that most prostate cancer is polygenic in origin. GWAS studies have identified more than 70 risk alleles and chromosomal loci, many of which occur in non-coding areas of the genome. A variety of genes implicated in prostate cancer initiation and progression include ** Hypermethylation of *** Hormonal response genes (ERαA, ERβ, and RARβ) *** Genes controlling the cell cycle (CyclinD2 and 14-3-3σ) *** Tumor cell invasion/tumor architecture genes (CD44) *** DNA repair genes (GSTpi, GPX3, and GSTM1) *** Tumor suppressor genes (APC, RASSF1α, DKK3, p16INK4?−α, E-cadherin, and p57WAF1) *** Signal transduction genes (EDNRB and SFRP1) *** Inflammatory response genes (PTGS/COX2) ** Hypomethylation of CAGE, HPSE, and PLAU ** Histone hypoacetylation of CAR, CPA3, RARB, and VDR ** Histone methylation of GSTP1 and PSA * Epigenetic mechanisms active in prostate cancer include: *# Chromatin remodeling *# Promoter hypomethylation and hypermethylation *# MicroRNAs that lead to gene silencing *# Long non-coding RNAs
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information